A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Ocugen, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 161,036 shares of OCGN stock, worth $90,180. This represents 0.0% of its overall portfolio holdings.

Number of Shares
161,036
Previous 172,612 6.71%
Holding current value
$90,180
Previous $170,000 24.71%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$0.72 - $1.08 $8,334 - $12,502
-11,576 Reduced 6.71%
161,036 $128,000
Q3 2024

Nov 14, 2024

BUY
$0.98 - $1.95 $139,748 - $278,071
142,601 Added 475.16%
172,612 $170,000
Q2 2024

Aug 14, 2024

BUY
$1.18 - $1.98 $35,412 - $59,421
30,011 New
30,011 $46,000

Others Institutions Holding OCGN

About Ocugen, Inc.


  • Ticker OCGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,566,000
  • Market Cap $121M
  • Description
  • Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...
More about OCGN
Track This Portfolio

Track Mirae Asset Global Etfs Holdings Ltd. Portfolio

Follow Mirae Asset Global Etfs Holdings Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.